Functional connectivity of the anterior cingulate cortex predicts treatment outcome for rTMS in treatment-resistant depression at 3-month follow-up
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND OBJECTIVE: Repetitive transcranial magnetic stimulation (rTMS) is a first-line treatment for treatment-resistant depression (TRD). The mechanisms of action of rTMS are not fully understood, and no biomarkers are available to assist in clinical practice to predict response to rTMS. This study aimed to demonstrate that after-rTMS clinical improvement is associated with functional connectivity (FC) changes of the subgenual cingulate cortex (sgACC) and rostral anterior cingulate (rACC), and FC of sgACC and rACC might serve as potential predictors for treatment response. METHODS: Resting-state functional magnetic resonance imaging (rs-fMRI) data were collected within 1 week before rTMS initiation in 50 TRD patients to predict subsequent response to rTMS on the left dorsolateral prefrontal cortex (DLPFC). Follow-up rs-fMRI was obtained 12 weeks after completion of rTMS and neural correlates of rTMS in sgACC- and rACC-related FC patterns were compared to before rTMS data and with rs-fMRI from healthy participants. RESULTS: Treatment response was associated with lower FC of sgACC to right DLPFC and higher FC of rACC to left lateral parietal cortex (IPL) measured at baseline. Using sgACC-DLPFC and rACC-IPL connectivity as features, responder-nonresponder classification accuracies of 84% and 76% (end-of-treatment), 88% and 81% (3-month follow-up), respectively were achieved. Longitudinal rs-fMRI data analyses revealed that the hyperconnectivity between sgACC and visual cortex was normalized to a level which was comparable to that of healthy participants. CONCLUSIONS: Brain activity patterns in depression are predictive of treatment response to rTMS, and longitudinal change of brain activity in relevant brain circuits after rTMS is associated with treatment response in depression. Target engagement paradigms may offer opportunities to increase the efficacy of rTMS in TRD by optimal selection of patients for treatment. TRIAL REGISTRATION: ClinicalTrials.gov Identifiers: NCT01887782 and NCT02800226.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Cohen, J. (2013) · doi:10.4324/9780203771587 · Cited by 25,373
Gusnard, D. A., Akbudak, E., Shulman, G. L., & Raichle, M. E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071043098 · Cited by 2,997
Kaiser, R. H., Andrews-Hanna, J. R., Wager, T. D., & Pizzagalli, D. A. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0071 · Cited by 2,281
Greicius, M. D., Flores, B. H., Menon, V., Glover, G. H., Solvason, H. B., Kenna, H., Reiss, A. L., & Schatzberg, A. F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.020 · Cited by 2,214 · cited 9×
“Please cite this article as: Ge R et al., Function resistant depression at 3-month follow-up, a b s t r a c t Background and objective: Repetitive transcranial magnetic stimulation (rTMS) is a first-line treatment for treatment-resistant depression (TRD).”
BackgroundInfluentialFunctional brain networks develop from a local to distributed organization
Fair, D. A., Cohen, A. L., Power, J. D., Dosenbach, N. U. F., Church, J. A., Miezin, F. M., Schlaggar, B. L., & Petersen, S. E. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000381 · Cited by 1,530
The default mode network and self-referential processes in depression
Sheline, Y. I., Barch, D. M., Price, J. L., Rundle, M. M., Vaishnavi, S. N., Snyder, A. Z., Mintun, M. A., Wang, S., Coalson, R. S., & Raichle, M. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812686106 · Cited by 1,480
Blumberger, D. M., Vila-Rodriguez, F., Thorpe, K. E., Feffer, K., Noda, Y., Giacobbe, P., Knyahnytska, Y., Kennedy, S. H., Lam, R. W., Daskalakis, Z. J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30295-2 · Cited by 1,363 · cited 3×
“Response was defined as 50% reduction in HRSD from baseline, remission was defined by a total score <8 as in the primary THREE-D analysis [25].”
BackgroundMethodInfluentialSelf-citationFox, M. D., Buckner, R. L., White, M. P., Greicius, M. D., & Pascual-Leone, A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.04.028 · Cited by 1,270 · cited 12×
“Please cite this article as: Ge R et al., Function resistant depression at 3-month follow-up, a b s t r a c t Background and objective: Repetitive transcranial magnetic stimulation (rTMS) is a first-line treatment for treatment-resistant depression (TRD).”
BackgroundResultInfluentialSheline, Y. I., Price, J. L., Yan, Z., & Mintun, M. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000446107 · Cited by 1,196
The brain's default network and its adaptive role in internal mentation
Andrews-Hanna, J. R. (2012) · The Neuroscientist · doi:10.1177/1073858411403316 · Cited by 1,114
The subgenual anterior cingulate cortex in mood disorders
Drevets, W. C., Savitz, J., & Trimble, M. (2008) · CNS Spectrums · doi:10.1017/s1092852900013754 · Cited by 1,109 · cited 10×
“Please cite this article as: Ge R et al., Function resistant depression at 3-month follow-up, a b s t r a c t Background and objective: Repetitive transcranial magnetic stimulation (rTMS) is a first-line treatment for treatment-resistant depression (TRD).”
BackgroundInfluentialFrontocingulate Dysfunction in Depression: Toward Biomarkers of Treatment Response
Pizzagalli, D. A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.166 · Cited by 945
Hamilton, J. P., Furman, D. J., Chang, C., Thomason, M. E., Dennis, E., & Gotlib, I. H. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.003 · Cited by 823
Default mode network mechanisms of transcranial magnetic stimulation in depression
Liston, C., Chen, A. C., Zebley, B. D., Drysdale, A. T., Gordon, R., Leuchter, B., Voss, H. U., Casey, B. J., Etkin, A., & Dubin, M. J. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.01.023 · Cited by 763
Grimm, S., Beck, J., Schuepbach, D., Hell, D., Boesiger, P., Bermpohl, F., Niehaus, L., Boeker, H., & Northoff, G. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.033 · Cited by 686 · cited 1×
“Specifically, it is involved in attentional modulation of emotional judgment inMDD patients [34,35], and its hyperactivity in an emotional task correlates with depression severity [34].”
BackgroundPizzagalli, D., Pascual-Marqui, R. D., Nitschke, J. B., Oakes, T. R., Larson, C. L., Abercrombie, H. C., Schaefer, S. M., Koger, J. V., Benca, R. M., & Davidson, R. J. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.405 · Cited by 630 · cited 1×
“However, contrary to the findings of sgACC, rACC activity has consistently been found to be hypoactive in nonresponders, relative to responders (see review by Pizzagalli [5]), treated with antidepressant medication [19], sleep deprivation [20], and rTMS [21,22].”
ResultThe neural substrates of affective processing in depressed patients treated with venlafaxine
Davidson, R. J., Irwin, W., Anderle, M. J., & Kalin, N. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.64 · Cited by 487
Fu, C. H. Y., Steiner, H., & Costafreda, S. G. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.05.008 · Cited by 399 · cited 1×
“Neuroimaging and neurophysiological measures have been proposed as potential biomarker candidates [2,3].”
BackgroundDunlop, B. W., Rajendra, J. K., Craighead, W. E., Kelley, M. E., McGrath, C. L., Choi, K. S., Kinkead, B., Nemeroff, C. B., & Mayberg, H. S. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16050518 · Cited by 342 · cited 2×
“Thus, FC and morphology of sgACC have been investigated as potential predictive biomarkers of treatment response in depression across diverse treatment modalities, including antidepressant medications [8,9], evidence-based psychotherapy [9,10], repetitive transcranial magnetic stimulation (rTMS) [11e14], and electroco…”
BackgroundResultDelaveau, P., Jabourian, M., Lemogne, C., Guionnet, S., Bergouignan, L., & Fossati, P. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.09.032 · Cited by 281 · cited 1×
“The abnormal activation of this region in emotional processing was normalized after antidepressant treatment [32].”
BackgroundPhillips, M. L., Chase, H. W., Sheline, Y. I., Etkin, A., Almeida, J. R. C., Deckersbach, T., & Trivedi, M. H. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14010076 · Cited by 267
Schaefer, H. S., Putnam, K. M., Benca, R. M., & Davidson, R. J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.024 · Cited by 158 · cited 1×
“Abnormality of fusiform activity in MDD patients has been repeatedly linked to perception of emotion with facial stimuli and declarative memory [29], and the abnormal neural activity of fusiform has been associated with symptoms of depression in both task state and resting state [30,31].”
BackgroundPretreatment Brain States Identify Likely Nonresponse to Standard Treatments for Depression
McGrath, C. L., Kelley, M. E., Dunlop, B. W., Holtzheimer III, P. E., Craighead, W. E., & Mayberg, H. S. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.12.005 · Cited by 139 · cited 2×
“Thus, FC and morphology of sgACC have been investigated as potential predictive biomarkers of treatment response in depression across diverse treatment modalities, including antidepressant medications [8,9], evidence-based psychotherapy [9,10], repetitive transcranial magnetic stimulation (rTMS) [11e14], and electroco…”
BackgroundResultBoes, A. D., Uitermarkt, B. D., Albazron, F. M., Lan, M. J., Liston, C., Pascual-Leone, A., Dubin, M. J., & Fox, M. D. (2018) · Brain Stimulation · doi:10.1016/j.brs.2018.01.029 · Cited by 94 · cited 1×
“Similar to the sgACC, the activity and morphology of rACC have also been proposed as promising biomarkers of treatment response in depression [18].”
MethodSubgenual cingulate cortical activity predicts the efficacy of electroconvulsive therapy
Argyelan, M., Lencz, T., Kaliora, S., Sarpal, D. K., Weissman, N., Kingsley, P. B., Malhotra, A. K., & Petrides, G. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.54 · Cited by 82 · cited 1×
“Thus, FC and morphology of sgACC have been investigated as potential predictive biomarkers of treatment response in depression across diverse treatment modalities, including antidepressant medications [8,9], evidence-based psychotherapy [9,10], repetitive transcranial magnetic stimulation (rTMS) [11e14], and electroco…”
BackgroundDemenescu, L. R., Renken, R., Kortekaas, R., van Tol, M.-J., Marsman, J. B. C., van Buchem, M. A., van der Wee, N. J. A., Veltman, D. J., den Boer, J. A., & Aleman, A. (2011) · Psychological Medicine · doi:10.1017/s0033291711000596 · Cited by 80
Cited by
The anatomy of pain and suffering in the brain and its clinical implications
De Ridder, D., Adhia, D., & Vanneste, S. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.08.013 · Cited by 269
Sezer, I., Pizzagalli, D. A., & Sacchet, M. D. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104583 · Cited by 214
“While a growing number of studies have investigated therapeutic effects of mindfulness meditation for MDD (e.g., meta-analyzed in Goldberg et al., 2016), only one has investigated the effects of mindfulness meditation on rsFC in MDD. Specifically, Lifshitz and colleagues used a seed-based approach to compare MDD patie…”
BackgroundInfluentialLong, Z., Du, L., Zhao, J., Wu, S., Zheng, Q., & Lei, X. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.06.072 · Cited by 136
Nakamura, T., Tomita, M., Horikawa, N., Ishibashi, M., Uematsu, K., Hiraki, T., Abe, T., & Uchimura, N. (2021) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12165 · Cited by 28
Metadata
- Authors
- Ge, R., Downar, J., Blumberger, D. M., Daskalakis, Z. J., & Vila-Rodriguez, F.
- Venue
- Brain Stimulation
- Publisher
- Elsevier BV
- Published
- 2020-01
- Volume
- 13
- Issue
- 1
- Pages
- 206-214
- ISSN
- 1876-4754 (ISSN-L)
- 1935-861X
- OpenAlex
- W2981151918
- Cited by
- 147
- References
- 26
- FWCI
- 5.46
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.